(Q72823760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

review article

1 reference

title

Pharmacology of antidepressants--characteristics of the ideal drug (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

E Richelson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 November 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

1069-1081

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

The treatment of depressive states with G 22355 (imipramine hydrochloride).

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Increasing rates of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

The efficacy of antidepressant drugs. A review of research (1958-1972).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Trimipramine kinetics and absolute bioavailability: use of gas-liquid chromatography with nitrogen-phosphorus detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Fluoxetine kinetics and protein binding in normal and impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Single and multiple oral dose fluvoxamine kinetics in young and elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Antidepressants: A Clinical Update for Medical Practitioners

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Discrepancies between pharmacokinetic studies of amitriptyline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Antidepressants and brain neurochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Neurobiological mechanisms involved in antidepressant therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Binding of antidepressants to human brain receptors: focus on newer generation compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Fluoxetine and extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Fluoxetine and anorgasmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Sertraline and extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: relationship with brain concentrations of fluoxetine and norfluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Histamine as a neuroregulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Highly potent and selective ligands for histamine H3-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

A cholinergic-adrenergic hypothesis of mania and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Adverse reactions suggesting amoxapine-induced dopamine blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

The effect of amoxapine and imipramine on serum prolactin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Plasma levels of trazodone: methodology and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Inhibitors of imipramine metabolism by human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Interactions between sertraline and tricyclic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

Trimipramine—an Atypical Neuroleptic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961375-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)61375-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967761%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference